For US Healthcare Professionals Only

Currently Viewing: 

Case Study: Advantages of Using Sotalol IV as a Loading Dose

Brad Knight, MD discusses the advantages of Sotalol IV at his practice for both patients and nursing staff

Description

Learn from Dr. Bradley Knight, Director of Cardiac Electrophysiology at Northwestern Medicine, what he views as the advantages of using Sotalol IV at his practice, and how it has benefited himself,  nursing staff, and patients.

Additional Resources Available

Whether you’re learning about Sotalol IV for the first time, are interested in adding it to your hospital’s formulary, or use it regularly, we have resources to support you. Visit our Resources page for more information. 

References

  1. Sotalol IV [package insert]. Chicago, IL: AltaThera Pharmaceuticals; 07/2025. sotaloliv.com/pi
  2. BetaPace [package insert]. Zug, Switzerland: Covis Pharma; 2023.

Dr. Knight’s appearance in this video was sponsored by AltaThera. 

SIV-VID-003.1-072025

This website is intended for US healthcare professionals only.

By selecting an option below, you certify that you are a licensed US healthcare professional and wish to view information regarding Sotalol IV (sotalol hydrochloride injection). 

I’m using Sotalol IV in…

View adult website

View pediatric website

Highlights of Prescribing Information

Boxed Warning, Indications, and Important Safety Information

WARNING: LIFE THREATENING PROARRHYTHMIA

Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue.